Registered entities
Hemab ApS
Reg. No. 40837590Denmark
Innovation
3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 68 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Social engagement
Social engagement: 11.8K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; lead investors include Novo Holdings, Healthcap, RA Capital Management, Access Industries.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 60% |
| Private equity | 2 | 20% |
| Other / undisclosed | 2 | 20% |
Recent activity
26 Jun 2026
Event
International Society on Thrombosis and Haemostasis (ISTH) Congress
27 May 2026
Event
Jefferies Global Healthcare Conference
6 May 2026
Milestone
regulatory